This move is archived. Current quotes and coverage live on the stock page.
Follow HEM
Hemostemix Inc. is facing significant losses in the market, with its stock price falling sharply.
Hemostemix Inc. (HEM.V) is experiencing a notable decline, with shares dropping by 7.14% in today's trading session. The stock closed at CA$0.07, reflecting investor concerns amid a lack of substantial news to support the company's valuation.
Advertisement
Hemostemix Inc
HEM.V
HEM.V
Hemostemix Inc
WealthAwesomeMarket cap
$11.63M
52W high
$0.13
52W low
$0.04
1W change
-7.14%
Beta
0.67
Analyst Price Targets
Based on analyst covering HEM · as of Sep 17, 2026
Wall Street analysts forecast HEM stock price to rise 1376.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.96
+1376.9% Upside
Current Price
C$0.07
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HEM's historical volatility
30-Day Vol
86.6%
Annualized
90-Day Vol
113.7%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.08
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.07 | C$0.05 – C$0.09 |
| 60 trading days | C$0.07 | C$0.05 – C$0.11 |
| 90 trading days | C$0.08 | C$0.05 – C$0.13 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should remain cautious with Hemostemix Inc. as the stock's recent performance suggests underlying weaknesses that could impact future growth.
Hemostemix Inc. shares drop 7.14% today
The company's market cap now stands at approximately CA$13.3 million, raising questions about its financial stability and growth potential.
Bull case
Despite today's setback, Hemostemix has been actively raising capital through private placements. This funding could be crucial for its ongoing projects and operational expenses, helping the company stay afloat during tough times.
Bear case
The sharp decline in stock price indicates potential investor skepticism about the company's prospects. With a low market cap and no recent positive news, many are questioning whether Hemostemix can turn things around.
Market Reaction
Advertisement
The market reaction to Hemostemix Inc.'s stock performance today reflects a growing concern among investors. The 7.14% drop raises questions about the company's future, especially given its low market cap of CA$13.3 million. Without significant news or developments, investor confidence appears to be waning.
Funding Efforts
Hemostemix has been actively engaging in private placements to raise capital, which is crucial for its ongoing projects and operational costs. The recent closures of multiple private placements, including a CDN$360,000 tranche, show that the company is trying to improve its financial position. However, the effectiveness of these efforts remains uncertain as the stock continues to struggle.
Looking Ahead
As Hemostemix Inc. navigates this challenging period, investors should keep a close eye on any forthcoming news or developments. The company's ability to leverage its recent funding for growth initiatives will be critical in restoring investor confidence and stabilizing its stock price.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
